| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/15/2002 | US20020110859 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/15/2002 | US20020110857 Nucleotide sequences coding polypeptide for use in the treatment of fat defects |
| 08/15/2002 | US20020110855 Mammalian secreted proteins |
| 08/15/2002 | US20020110853 Polypeptide; for use in the treatment of tumors |
| 08/15/2002 | US20020110852 Peptide; for use in the treatment of pancreatic defects |
| 08/15/2002 | US20020110851 Polypeptide for use in treatment of cancer, vascular, liver, autoimmune and nervous system disorders |
| 08/15/2002 | US20020110841 Regulation of cell growth by MUC1 |
| 08/15/2002 | US20020110836 PD-L2 molecules: novel PD-1 ligands and uses therefor |
| 08/15/2002 | US20020110832 Compositions and methods for the therapy and diagnosis of colon cancer |
| 08/15/2002 | US20020110826 Oligonucleotide probe for use in hybridization analysis |
| 08/15/2002 | US20020110815 Nucleotide sequences which code polypeptide for use in the treatment of tumors |
| 08/15/2002 | US20020110809 Novel human polynucleotides and polypeptides encoded thereby |
| 08/15/2002 | US20020110808 Profiling preferential gene expression; obtain cells, transform with expression vector containing preferential genes, recover transformed cells, incubate with modulator, monitor gene expression in presence and absence of modulator |
| 08/15/2002 | US20020110805 Peptide for use in the treatment of glomerulonephritis, psoriasis, leukemia, antherosclerosis, autoimmune diseases, inflammatory, arthritic, asthmatic, and fibrotic disorders |
| 08/15/2002 | US20020110804 Secreted factors |
| 08/15/2002 | US20020110569 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 08/15/2002 | US20020110563 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/15/2002 | US20020110562 Streptococcus pneumoniae proteins and vaccines |
| 08/15/2002 | US20020110559 Confering an immune response to a tumor cell in a mammal by administering antibody which binds to aspartyl (asparaginyl) beta hydroxylase (HAAH) |
| 08/15/2002 | US20020110557 Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
| 08/15/2002 | US20020110547 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 08/15/2002 | US20020110545 Adenovector pharmaceutical composition |
| 08/15/2002 | US20020110542 Dna immunization against chlamydia infection |
| 08/15/2002 | US20020110535 Multivalent platform molecules comprising high molecular weight polyethylene oxide |
| 08/15/2002 | US20020108217 Jewelry closure |
| 08/15/2002 | CA2447905A1 Hyperblebbing bacterial strains and use thereof for production of vaccines |
| 08/15/2002 | CA2438376A1 Method and apparatus for the production of antigens and uses thereof |
| 08/15/2002 | CA2438018A1 Markers of unstable atherosclerotic plaques |
| 08/15/2002 | CA2437750A1 Prc17: an amplified cancer gene |
| 08/15/2002 | CA2437727A1 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 08/15/2002 | CA2437717A1 G-protein coupled receptors |
| 08/15/2002 | CA2437714A1 Platlet glycoprotein ib alpha fusion polypeptides and methods of use thereof |
| 08/15/2002 | CA2437700A1 Regulation of cc chemokine receptor 3 (ccr3) expression |
| 08/15/2002 | CA2437606A1 Plant-derived molecules and genetic sequences encoding same and uses therefor |
| 08/15/2002 | CA2437573A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437572A1 Method for the production of plant seed with modified fibre content and modified seed coat |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437570A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437564A1 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/15/2002 | CA2437503A1 Hepatitis b virus treatment |
| 08/15/2002 | CA2437497A1 Lipid-associated molecules |
| 08/15/2002 | CA2437484A1 Ragweed allergens |
| 08/15/2002 | CA2437453A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 08/15/2002 | CA2437423A1 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 08/15/2002 | CA2437318A1 Nucleotide sequence mediating male fertility and method of using same |
| 08/15/2002 | CA2437276A1 Isolated human ras-like proteins, nucleic acid molecules encoding them, and uses thereof |
| 08/15/2002 | CA2437272A1 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | CA2437270A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity |
| 08/15/2002 | CA2437267A1 Mixture of peptides originating from a nef protein and applications thereof |
| 08/15/2002 | CA2437265A1 Modified leptin with reduced immunogenicity |
| 08/15/2002 | CA2437263A1 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity |
| 08/15/2002 | CA2437214A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity |
| 08/15/2002 | CA2437185A1 Timm8b-related protein |
| 08/15/2002 | CA2436986A1 Ter sites and ter binding proteins |
| 08/15/2002 | CA2436470A1 Intracellular signaling molecules |
| 08/15/2002 | CA2436435A1 Vaccine composition |
| 08/15/2002 | CA2436334A1 Adhesion molecules |
| 08/15/2002 | CA2435835A1 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer |
| 08/15/2002 | CA2435563A1 Long lasting growth hormone releasing factor derivatives |
| 08/15/2002 | CA2435292A1 Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn1 |
| 08/15/2002 | CA2434945A1 Thermodynamic propensities of amino acids in the native state ensemble: implications for fold recognition |
| 08/15/2002 | CA2434944A1 Secreted proteins |
| 08/15/2002 | CA2434045A1 Improved protein disaggregation and refolding using high pressure |
| 08/15/2002 | CA2433439A1 Proteins and nucleic acids encoding same |
| 08/15/2002 | CA2404289A1 Muc1 isolation from bovine milk and whey |
| 08/14/2002 | EP1231278A1 Cell-free method for preparing post-translational modified proteins |
| 08/14/2002 | EP1231277A2 Biocompatible implant for in vivo formation of a neo-organ |
| 08/14/2002 | EP1231276A1 Method for purifying proteins and/or biomolecule of protein complexes |
| 08/14/2002 | EP1231275A2 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/14/2002 | EP1231274A2 Modified porteinase inhibitors |
| 08/14/2002 | EP1231271A2 DNA fragments of the GAG gene of Lav. |
| 08/14/2002 | EP1231270A1 Novel protein and dna thereof |
| 08/14/2002 | EP1231269A1 Methods and compositions for polypeptide engineering |
| 08/14/2002 | EP1231265A2 A receptor protein tyrosine kinase |
| 08/14/2002 | EP1231261A2 A method for isolating cells that express FLK-1 receptors on their surface |
| 08/14/2002 | EP1231260A2 A method for isolating cells that express FLK-2 receptors on their surface |
| 08/14/2002 | EP1231220A1 Modified factor VIII cDNa and its use for the production of factor VIII |
| 08/14/2002 | EP1231219A1 GLucagon-like peptide-2 analogs |
| 08/14/2002 | EP1231218A2 An appetite-suppressing peptide, its compositions and use |
| 08/14/2002 | EP1231217A2 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/14/2002 | EP1231216A2 Human gtp-rho binding protein 2 |
| 08/14/2002 | EP1230930A2 Bmp-9 compositions |
| 08/14/2002 | EP1230929A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 08/14/2002 | EP1230843A1 Method for lowering pollen fertility by using pollen-specific zinc finger transcriptional factor genes |
| 08/14/2002 | EP1230551A2 Methods to identify compounds that modulate neuronal activity |
| 08/14/2002 | EP1230377A2 Modulation of plant response to abscisic acid |
| 08/14/2002 | EP1230372A2 SUNFLOWER RhoGAP, LOX, ADH, AND SCIP-1 POLYNUCLEOTIDES AND METHODS OF USE |
| 08/14/2002 | EP1230371A2 Method for producing recombinant interleucin-8 and interleucin-8 muteins |
| 08/14/2002 | EP1230370A2 Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same |
| 08/14/2002 | EP1230369A2 Polypeptide hormone phosphatonin |
| 08/14/2002 | EP1230368A2 Mammalian receptor proteins; related reagents and methods |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230365A2 Bt toxin receptors from lepidopteran insects and methods of use |
| 08/14/2002 | EP1230364A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 08/14/2002 | EP1230363A2 Educational kit and method using colipase-like protein-1 |
| 08/14/2002 | EP1230362A2 Human zven proteins |
| 08/14/2002 | EP1230361A2 G protein-coupled receptors expressed in human brain |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230359A1 Chordin-like homologs |